Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2003

01.10.2003 | Original Article

Bone remodeling and bone mineral density during pregnancy

verfasst von: U. Ulrich, P. B. Miller, D. R. Eyre, C. H. Chesnut III, H. Schlebusch, M. R. Soules

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Abstract

Introduction.

The effect of pregnancy upon the maternal skeleton is not fully understood. The information that has been gathered by recent studies is conflicting with regard to overall loss or gain of bone during pregnancy. The aim of the present longitudinal, controlled study, therefore, was to investigate the effect of pregnancy on lumbar spine, wrist, and hip bone mineral density, and to describe bone remodeling during pregnancy as indicated by biochemical markers of both bone resorption and formation.

Materials and methods.

Thirty healthy women (15 subjects seeking pregnancy and 15 non-pregnant controls) were studied. Bone mineral density (BMD) was measured by dual-energy x-ray absorptiometry before conception and within 2 weeks after parturition. Markers of bone resorption (urinary cross-linked type I collagen N-telopeptides, serum type I collagen C-telopeptides) and bone formation (total and bone specific alkaline phosphatase, osteocalcin), and total serum calcium were analyzed before, during (once in each trimester), and after pregnancy.

Results.

During pregnancy, BMD decreased significantly by 3.4±4.1% at the lumbar spine and 4.3±3.9% at the trochanter, while there was a slight but significant increase in BMD at the proximal 1/3 of the forearm (1.3±1.9%). Total hip and femoral neck BMD did not change significantly, nor did total and ultradistal forearm BMD. Bone resorption increased during pregnancy with peak levels in the third trimester (N-telopeptides) or post partum (C-telopeptides), respectively. The increase in bone resorption was accompanied by a significant decrease in serum calcium in the third trimester. Markers of bone formation showed a biphasic pattern with decreases from baseline to the first (total and bone specific alkaline phosphatase) or second trimester (osteocalcin), respectively, followed by a significant increase in the third trimester and post partum. There was no change in any parameter in the control group throughout the study.

Conclusion.

In conclusion, pregnancy is characterized by high bone turnover with resorption preceding formation. During the first and second trimester bone remodeling is uncoupled. Serum calcium decreases as bone resorption peaks in late pregnancy. There are significant decreases in bone mineral density at sites rich in trabecular bone, such as the lumbar spine and the trochanter.
Literatur
1.
Zurück zum Zitat Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD (2000) A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 15:557–563CrossRefPubMed Black AJ, Topping J, Durham B, Farquharson RG, Fraser WD (2000) A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res 15:557–563CrossRefPubMed
2.
Zurück zum Zitat Christiansen C, Rodbro P, Heinild B (1976) Unchanged total body calcium in normal human pregnancy. Acta Obstet Gynecol Scand 55:141–143CrossRefPubMed Christiansen C, Rodbro P, Heinild B (1976) Unchanged total body calcium in normal human pregnancy. Acta Obstet Gynecol Scand 55:141–143CrossRefPubMed
3.
Zurück zum Zitat Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE (1995) Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 61:514–523PubMed Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NE (1995) Calcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal study. Am J Clin Nutr 61:514–523PubMed
4.
Zurück zum Zitat Dahlman T, Sjöberg HE, Ringertz H (1994) Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 170:1315–1320CrossRefPubMed Dahlman T, Sjöberg HE, Ringertz H (1994) Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 170:1315–1320CrossRefPubMed
5.
Zurück zum Zitat Drinkwater BL, Chesnut CH III (1991) Bone density during pregnancy and lactation in active women: a longitudinal study. Bone Miner 14:153–160CrossRefPubMed Drinkwater BL, Chesnut CH III (1991) Bone density during pregnancy and lactation in active women: a longitudinal study. Bone Miner 14:153–160CrossRefPubMed
6.
Zurück zum Zitat Gallacher SJ, Fraser WD, Owens OJ, Dryburgh FJ, Logue FC, Jenkins A, Kennedy J, Boyle IT (1994) Changes in calcitropic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 131:369–374CrossRefPubMed Gallacher SJ, Fraser WD, Owens OJ, Dryburgh FJ, Logue FC, Jenkins A, Kennedy J, Boyle IT (1994) Changes in calcitropic hormones and biochemical markers of bone turnover in normal human pregnancy. Eur J Endocrinol 131:369–374CrossRefPubMed
7.
Zurück zum Zitat Goss H, Schmidt CLA (1930) Calcium and phosphorus metabolism in rats during pregnancy and lactation and the influence of the reaction of the diet thereon. J Biol Chem 86:417–432 Goss H, Schmidt CLA (1930) Calcium and phosphorus metabolism in rats during pregnancy and lactation and the influence of the reaction of the diet thereon. J Biol Chem 86:417–432
8.
Zurück zum Zitat Hosking DJ (1996) Calcium homeostasis in pregnancy. Clin Endocrinol (Oxf) 45:1–6 Hosking DJ (1996) Calcium homeostasis in pregnancy. Clin Endocrinol (Oxf) 45:1–6
9.
Zurück zum Zitat Khastgir G, Studd JWW, King H, Abdalla H, Jones J, Carter G, Alaghband-Zadeh J (1996) Changes in bone density and biochemical markers of bone turnover in pregnancy-associated osteoporosis. Br J Obstet Gynaecol 103:716–718CrossRefPubMed Khastgir G, Studd JWW, King H, Abdalla H, Jones J, Carter G, Alaghband-Zadeh J (1996) Changes in bone density and biochemical markers of bone turnover in pregnancy-associated osteoporosis. Br J Obstet Gynaecol 103:716–718CrossRefPubMed
10.
Zurück zum Zitat Lamke B, Brundin J, Moberg P (1977) Changes of bone mineral content during pregnancy and lactation. Acta Obstet Gynecol Scand 56:217–219CrossRefPubMed Lamke B, Brundin J, Moberg P (1977) Changes of bone mineral content during pregnancy and lactation. Acta Obstet Gynecol Scand 56:217–219CrossRefPubMed
11.
Zurück zum Zitat Matsumoto I, Kosha S, Noguchi S, Kojima N, Oki T, Douchi T, Nagata Y (1995) Changes of bone mineral density in pregnant and postpartum women. J Obstet Gynaecol 21:419–425CrossRef Matsumoto I, Kosha S, Noguchi S, Kojima N, Oki T, Douchi T, Nagata Y (1995) Changes of bone mineral density in pregnant and postpartum women. J Obstet Gynaecol 21:419–425CrossRef
12.
Zurück zum Zitat Melton LJ III, Bryant SC, Wahner HW, O'Fallon WM, Malkasian GD, Judd HL, Riggs BL (1993) Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int 3:76–83CrossRefPubMed Melton LJ III, Bryant SC, Wahner HW, O'Fallon WM, Malkasian GD, Judd HL, Riggs BL (1993) Influence of breastfeeding and other reproductive factors on bone mass later in life. Osteoporos Int 3:76–83CrossRefPubMed
13.
Zurück zum Zitat Miller SC, Shupe JG, Redd EH, Miller MA, Omura TH (1986) Changes in bone mineral and bone formation rates during pregnancy and lactation in rats. Bone 7:283–287CrossRefPubMed Miller SC, Shupe JG, Redd EH, Miller MA, Omura TH (1986) Changes in bone mineral and bone formation rates during pregnancy and lactation in rats. Bone 7:283–287CrossRefPubMed
14.
Zurück zum Zitat Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R (2000) The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 15:129–137CrossRefPubMed Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R (2000) The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 15:129–137CrossRefPubMed
15.
Zurück zum Zitat Nordin BEC, Roper A (1955) Post-pregnancy osteoporosis. A syndrome? Lancet 1:431–434CrossRef Nordin BEC, Roper A (1955) Post-pregnancy osteoporosis. A syndrome? Lancet 1:431–434CrossRef
16.
Zurück zum Zitat Purdie DW, Aaron JE, Selby PL (1988) Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 95:849–854CrossRefPubMed Purdie DW, Aaron JE, Selby PL (1988) Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol 95:849–854CrossRefPubMed
17.
Zurück zum Zitat Rodin A, Duncan A, Quartero HWP, Pistofidis G, Mashiter G, Whitaker K, Crook D, Stevenson JC, Chapman MG (1989) Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy. J Clin Endocrinol Metab 68:1123–1127CrossRefPubMed Rodin A, Duncan A, Quartero HWP, Pistofidis G, Mashiter G, Whitaker K, Crook D, Stevenson JC, Chapman MG (1989) Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy. J Clin Endocrinol Metab 68:1123–1127CrossRefPubMed
18.
Zurück zum Zitat Shahtaheri SM, Aaron JE, Johnson DR, Purdie DW (1999) Changes in trabecular bone architecture in women during pregnancy. Br J Obstet Gynaecol 106:432–438CrossRefPubMed Shahtaheri SM, Aaron JE, Johnson DR, Purdie DW (1999) Changes in trabecular bone architecture in women during pregnancy. Br J Obstet Gynaecol 106:432–438CrossRefPubMed
19.
Zurück zum Zitat Sowers MF (1996) Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 11:1052–1060CrossRefPubMed Sowers MF (1996) Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res 11:1052–1060CrossRefPubMed
20.
Zurück zum Zitat Sowers MF, Crutchfield M, Jannausch M, Updike S, Corton G (1991) A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 77:841–845PubMed Sowers MF, Crutchfield M, Jannausch M, Updike S, Corton G (1991) A prospective evaluation of bone mineral change in pregnancy. Obstet Gynecol 77:841–845PubMed
21.
Zurück zum Zitat Sowers MF, Randolph J, Shapiro B, Jannausch M (1995) A prospective study of bone density and pregnancy after an extended period of lactation with bone loss. Obstet Gynecol 85:285–289CrossRefPubMed Sowers MF, Randolph J, Shapiro B, Jannausch M (1995) A prospective study of bone density and pregnancy after an extended period of lactation with bone loss. Obstet Gynecol 85:285–289CrossRefPubMed
22.
Zurück zum Zitat Sowers MF, Scholl T, Harris L, Jannausch M (2000) Bone loss in adolescent and adult pregnant women. Obstet Gynecol 96:189–193PubMed Sowers MF, Scholl T, Harris L, Jannausch M (2000) Bone loss in adolescent and adult pregnant women. Obstet Gynecol 96:189–193PubMed
23.
Zurück zum Zitat Ulrich U, Pfeifer T, Lauritzen C (1994) Rapid increase in lumbar spine bone density by high-dose intramuscular estrogen-progestogen injections: a preliminary report. Horm Metab Res 26:428–431CrossRefPubMed Ulrich U, Pfeifer T, Lauritzen C (1994) Rapid increase in lumbar spine bone density by high-dose intramuscular estrogen-progestogen injections: a preliminary report. Horm Metab Res 26:428–431CrossRefPubMed
24.
Zurück zum Zitat Ulrich U, Pfeifer T, Buck G, Lauritzen C (1995) Osteopenia in primary and secondary amenorrhea. Horm Metab Res 27:432–435CrossRefPubMed Ulrich U, Pfeifer T, Buck G, Lauritzen C (1995) Osteopenia in primary and secondary amenorrhea. Horm Metab Res 27:432–435CrossRefPubMed
25.
Zurück zum Zitat Yamaga A, Taga M, Minaguchi H, Sato K (1996) Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. J Clin Endocrinol Metab 81:752–756PubMed Yamaga A, Taga M, Minaguchi H, Sato K (1996) Changes in bone mass as determined by ultrasound and biochemical markers of bone turnover during pregnancy and puerperium: a longitudinal study. J Clin Endocrinol Metab 81:752–756PubMed
26.
Zurück zum Zitat Yamaga A, Taga M, Minaguchi H (1997) Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium. Endocr J 44:733–738CrossRefPubMed Yamaga A, Taga M, Minaguchi H (1997) Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium. Endocr J 44:733–738CrossRefPubMed
27.
Zurück zum Zitat Yasumizu T, Kato J (1996) Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. Endocr J 43:191–195CrossRefPubMed Yasumizu T, Kato J (1996) Concentrations of serum markers of type I collagen synthesis and degradation and serum osteocalcin in maternal and umbilical circulation. Endocr J 43:191–195CrossRefPubMed
Metadaten
Titel
Bone remodeling and bone mineral density during pregnancy
verfasst von
U. Ulrich
P. B. Miller
D. R. Eyre
C. H. Chesnut III
H. Schlebusch
M. R. Soules
Publikationsdatum
01.10.2003
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2003
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-002-0410-8

Weitere Artikel der Ausgabe 4/2003

Archives of Gynecology and Obstetrics 4/2003 Zur Ausgabe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.